Literature DB >> 10426360

The pathology of multiple sclerosis: a historical perspective.

W F Hickey1.   

Abstract

In the century and a half since multiple sclerosis (MS) was first recognized, the pathology of the condition has been defined with increasing detail. From the recognition and definition of MS as a clinical phenomenon, studies of the diseased brain tissue have progressed in a manner dependent on the science of the time. Through multiple generations, the increasingly detailed analysis of the MS lesion itself has lead to an increasingly sophisticated understanding of a complex, apparently diverse, immunopathological process. During this evolution, many hypotheses concerning the pathogenesis of MS have been overturned, and the interpretation of some clearly delineated gross and histological findings have been reversed. This review plots the progress and highlights current theories and emerging concepts regarding one of the most enigmatic of neurological diseases.

Entities:  

Mesh:

Year:  1999        PMID: 10426360     DOI: 10.1016/s0165-5728(99)00079-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  28 in total

1.  Enhancing patterns in multiple sclerosis: evolution and persistence.

Authors:  J He; R I Grossman; Y Ge; L J Mannon
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

Review 2.  Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors.

Authors:  Adam Elhofy; Kevin J Kennedy; Brian T Fife; William J Karpus
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

Authors:  R J Butterfield; E P Blankenhorn; R J Roper; J F Zachary; R W Doerge; C Teuscher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 4.  Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  Xu Zhang; Raymond Hupperts; Marc De Baets
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 5.  Intestinal macrophages: differentiation and involvement in intestinal immunopathologies.

Authors:  Benjamin Weber; Leslie Saurer; Christoph Mueller
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 6.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

7.  Regulation of microglial development: a novel role for thyroid hormone.

Authors:  F R Lima; A Gervais; C Colin; M Izembart; V M Neto; M Mallat
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

8.  CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Authors:  Eileen A Forde; Rukiye-Nazan E Dogan; William J Karpus
Journal:  J Neuroimmunol       Date:  2011-05-14       Impact factor: 3.478

Review 9.  [Georg Schaltenbrand (1897-1979) and his research without moral boundaries on multiple sclerosis].

Authors:  Michael Martin; Heiner Fangerau; Axel Karenberg
Journal:  Nervenarzt       Date:  2020-02       Impact factor: 1.214

10.  Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury.

Authors:  Michael P Kurnellas; Arnaud Nicot; Gary E Shull; Stella Elkabes
Journal:  FASEB J       Date:  2004-12-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.